Bioadaptives Stock Alpha and Beta Analysis

BDPT Stock  USD 0.08  0.01  14.29%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioAdaptives. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioAdaptives over a specified time horizon. Remember, high BioAdaptives' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioAdaptives' market risk premium analysis include:
Beta
(421.74)
Alpha
352.93
Risk
129.92
Sharpe Ratio
0.15
Expected Return
19.14
Please note that although BioAdaptives alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, BioAdaptives did 352.93  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of BioAdaptives stock's relative risk over its benchmark. BioAdaptives has a beta of 421.74  . As returns on the market increase, returns on owning BioAdaptives are expected to decrease by larger amounts. On the other hand, during market turmoil, BioAdaptives is expected to outperform it. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out BioAdaptives Backtesting, BioAdaptives Valuation, BioAdaptives Correlation, BioAdaptives Hype Analysis, BioAdaptives Volatility, BioAdaptives History and analyze BioAdaptives Performance.

BioAdaptives Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioAdaptives market risk premium is the additional return an investor will receive from holding BioAdaptives long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioAdaptives. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioAdaptives' performance over market.
α352.93   β-421.74

BioAdaptives expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BioAdaptives' Buy-and-hold return. Our buy-and-hold chart shows how BioAdaptives performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

BioAdaptives Market Price Analysis

Market price analysis indicators help investors to evaluate how BioAdaptives pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioAdaptives shares will generate the highest return on investment. By understating and applying BioAdaptives pink sheet market price indicators, traders can identify BioAdaptives position entry and exit signals to maximize returns.

BioAdaptives Return and Market Media

The median price of BioAdaptives for the period between Wed, Sep 4, 2024 and Tue, Dec 3, 2024 is 7.0E-4 with a coefficient of variation of 222.67. The daily time series for the period is distributed with a sample standard deviation of 0.03, arithmetic mean of 0.01, and mean deviation of 0.02. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About BioAdaptives Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioAdaptives or other pink sheets. Alpha measures the amount that position in BioAdaptives has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioAdaptives in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioAdaptives' short interest history, or implied volatility extrapolated from BioAdaptives options trading.

Build Portfolio with BioAdaptives

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for BioAdaptives Pink Sheet Analysis

When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.